Elekta AB (EKTAY)
6.75
-0.17
(-2.46%)
USD |
OTCM |
Apr 25, 10:12
Elekta Free Cash Flow (Quarterly): 57.34M for Jan. 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 57.34M |
October 31, 2023 | 22.33M |
July 31, 2023 | -84.96M |
April 30, 2023 | 150.71M |
January 31, 2023 | -18.15M |
October 31, 2022 | -35.03M |
July 31, 2022 | -59.08M |
April 30, 2022 | 69.87M |
January 31, 2022 | 22.54M |
October 31, 2021 | -1.025M |
July 31, 2021 | -40.60M |
April 30, 2021 | 89.90M |
January 31, 2021 | 61.24M |
October 31, 2020 | 37.61M |
July 31, 2020 | 6.531M |
April 30, 2020 | 89.41M |
January 31, 2020 | -17.03M |
October 31, 2019 | 31.03M |
July 31, 2019 | -77.21M |
April 30, 2019 | 135.64M |
January 31, 2019 | -17.40M |
October 31, 2018 | 46.40M |
July 31, 2018 | -58.04M |
April 30, 2018 | 98.19M |
January 31, 2018 | 63.62M |
Date | Value |
---|---|
October 31, 2017 | 31.26M |
July 31, 2017 | -6.045M |
April 30, 2017 | 116.66M |
January 31, 2017 | 25.78M |
October 31, 2016 | 14.06M |
July 31, 2016 | -36.77M |
April 30, 2016 | 62.07M |
January 31, 2016 | 22.15M |
October 31, 2015 | 22.21M |
July 31, 2015 | -60.47M |
April 30, 2015 | 155.75M |
January 31, 2015 | 6.911M |
October 31, 2014 | 43.54M |
July 31, 2014 | -92.96M |
April 30, 2014 | 132.42M |
January 31, 2014 | 3.363M |
October 31, 2013 | 22.51M |
July 31, 2013 | -74.11M |
April 30, 2013 | 125.77M |
January 31, 2013 | 7.299M |
October 31, 2012 | 78.36M |
July 31, 2012 | -12.53M |
April 30, 2012 | 41.55M |
January 31, 2012 | 44.08M |
October 31, 2011 | 31.08M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-84.96M
Minimum
Jul 2023
150.71M
Maximum
Apr 2023
22.05M
Average
22.43M
Median
Free Cash Flow (Quarterly) Benchmarks
Abliva AB | -0.4612M |
Karolinska Development AB | -0.5043M |
Calliditas Therapeutics AB | -- |
Oncopeptides AB | -4.947M |
Olink Holding AB | -11.09M |